Abstracts Archive - Page 1148 of 2425 - ACR Meeting Abstracts

Abstract Number: 2152 • 2018 ACR/ARHP Annual Meeting
A Comparison of the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics Classification (SLICC) Criteria to Detect Patients with Systemic Lupus Erythematosus (SLE) in Electronic Health Record (EHR) Data
Theresa L. Walunas¹, Anika S. Ghosh², Kathryn L. Jackson³, Ahn H. Chun², Daniel L. Erickson², Karen Mancera-Cuevas⁴, Abel N. Kho² and Rosalind Ramsey-Goldman⁵, ¹Department of Medicine, Division of General Internal Medicine and Geriatrics, Northwestern University, Chicago, IL, ²Northwestern University, Chicago, IL, ³Center for Health Information Partnerships, Northwestern University, Chicago, IL, ⁴Rheumatology, Northwestern University, Chicago, IL, ⁵FSM, Northwestern University, Chicago, IL
Background/Purpose: Systemic Lupus Erythematosus is a systemic autoimmune disease that has diverse manifestations that can occur over a long period of time. The complexity of…
Abstract Number: 2153 • 2018 ACR/ARHP Annual Meeting
The Effect of Socioeconomic Status on Treatment Outcomes in Lupus Nephritis: Private Versus Public Insurance
Arezoo Haghshenas¹, Phildrich Teh², Kristal Choi³, Abigail Benitez⁴, Lorena Salto³, Mathew Firek⁵, Karina Torralba⁶ and Vaneet K. Sandhu¹, ¹Division of Rheumatology, Loma Linda University, Loma Linda, CA, ²Internal Medicine, University of California, Riverside, Riverside, CA, ³Loma Linda University, Loma Linda, CA, ⁴Rheumatology, Loma Linda University, Loma Linda, CA, ⁵Riverside university health system, Moreno valley, CA, ⁶Loma Linda University Medical Center, Loma Linda, CA
Background/Purpose: Despite therapeutic advancements, lupus nephritis (LN) remains a major cause of mortality among patients with SLE. Loma Linda University Health serves a region in…
Abstract Number: 2154 • 2018 ACR/ARHP Annual Meeting
Biosimilar Infliximab Treated-Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis in France: Characteristics and Clinical Outcomes
Hubert Marotte¹, NADIR MAMMAR² and Bruno Fautrel³, ¹University Hospital of Saint Etienne,, Saint Etienne, France, ²Pfizer, PARIS, France, ³Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), UMR S 1136, Sorbonne Université, GRC-UPMC 08, Paris, France
Background/Purpose: CT-P13 was the first monoclonal antibody biosimilar to infliximab (IFX) approved in France. Reflect trial has been set up to evaluate in real life…
Abstract Number: 2155 • 2018 ACR/ARHP Annual Meeting
Diagnosis of Systemic Sclerosis in the United Kingdom: An Observational Study Using the Clinical Practice Research Datalink
Alicia Gayle¹, Nils Schoof², Margarida Alves², Deborah Clarke³, Chris Poole¹, Christina Raabe², Prithwiraj Das¹ and Toby Maher⁴, ¹Boehringer Ingelheim Ltd., Bracknell, United Kingdom, ²Boehringer Ingelheim International GmbH, Ingelheim, Germany, ³Department of Medical Affairs, Boehringer Ingelheim Ltd., Bracknell, United Kingdom, ⁴University College London and Royal Brompton Hospital, London, United Kingdom
Background/Purpose: Systemic Sclerosis (SSc) is an autoimmune disease that is characterised by fibroblast dysfunction and excess extracellular matrix deposition that leads to skin thickening and…
Abstract Number: 2156 • 2018 ACR/ARHP Annual Meeting
Smoking Status Predicts Earlier SLICC Damage Index Progression in a Large SLE Cohort
Trevor McKown¹, Rachna Unnithan¹, Nnenna Ezeh¹, Ting Ye² and Christie M. Bartels¹, ¹Rheumatology/Medicine, University of Wisconsin - Madison, Madison, WI, ²Biostatistics and Medical Informatics, University of Wisconsin - Madison, Madison, WI
Background/Purpose: Tobacco smoking predisposes to certain specific manifestations of systemic lupus erythematosus (SLE); however, less is known about smoking and cumulative organ damage in SLE.…
Abstract Number: 2157 • 2018 ACR/ARHP Annual Meeting
Nationwide Estimated Prevalence of SLE: United States Population-Based Study, 2001-2011
KimNgan P. Nguyen¹, Eric Yen², Ning Li³ and Ram R. Singh², ¹David Geffen School of Medicine, UCLA, LOS ANGELES, CA, ²UCLA, Los Angeles, CA, ³Biomathematics, University of California, Los Angeles, Los Angeles, CA
Background/Purpose: In the published literature, the prevalence rates of SLE have widely varied by as much as 12-fold over the years. This is likely due…
Abstract Number: 2158 • 2018 ACR/ARHP Annual Meeting
Clinical Significance of Anti-Ro52 Antibody in Chinese Patients with Connective Tissue Diseases: A Single-Center Experience
Si Wu, Xiaojun Tang and Xuebing Feng, Department of Rheumatology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
Background/Purpose: Autoantibody targeting Ro52 has been implied as a unique antibody with distinct clinical properties. However, its relations with anti-Ro60 antibody and various connective tissue…
Abstract Number: 2159 • 2018 ACR/ARHP Annual Meeting
Autoimmune Diseases in Catalonia: A Population Based Study Using a Public Big Data Program
Antoni Sisó-Almirall^1,2,3, Belchin Kostov^1,2,3, Elisenda Martínez Carbonell⁴, Soledad Retamozo^5,6,7, Alejandra Flores-Chavez^8,9,10, S. González-Martínez^1,2,3, Pilar Brito-Zerón⁵, Antoni Dedéu Baraldés¹¹, Jaume Benavent Àreu^1,2,3 and Manuel Ramos-Casals^2,12, ¹Consorci d’Atenció Primària de Salut Barcelona Esquerre (CAPSBE), Barcelona, Spain, ²Departament de Medicina, Universitat de Barcelona, Barcelona, Spain, ³Grup de Recerca Transversal en Atenció Primària, IDIBAPS, Barcelona, Barcelona, Spain, ⁴Agency for Health Quality and Assessment of Catalonia (AQuAS). Ministry of Health, Catalonia., Barcelona, Spain, ⁵Department of Autoimmune Diseases, ICMiD, Hospital Clínic Barcelona, Barcelona, Spain, ⁶Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Córdoba, Consejo Nacional de Investigaciones Científicas y Técnicas (INICSA-UNC-CONICET), Cordoba, Argentina, ⁷Rheumatology Unit, Hospital Privado Universitario de Córdoba, Institute University of Biomedical Sciences University of Córdoba (IUCBC), Cordoba, Argentina, ⁸Department of Autoimmune Diseases, ICMiD, Hospital Clínic Barcelona, Spain., Barcelona, Spain, ⁹Unidad de Investigación Biomédica 02, Unidad de Investigación en Epidemiología Clínica, Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Hospital de Especialidades, Guadalajara, Guadalajara, Mexico, ¹⁰Programa de Doctorado en Ciencias Médicas, Centro Universitario de Investigaciones Biomédicas (CUIB), Universidad de Colima, Colima, Mexico, Mexico, Mexico, ¹¹Agency for Health Quality and Assessment of Catalonia (AQuAS). Ministry of Health, Catalonia, Barcelona, Spain, ¹²Department of Autoimmune Diseases, ICMiD, Hospital Clínic Barcelona., Barcelona, Spain
Background/Purpose: To analyse the prevalence of autoimmune diseases (ADs) in Catalonia by using a public big data program (Public Data Analysis for Health Research and…
Abstract Number: 2160 • 2018 ACR/ARHP Annual Meeting
Effect of the Metabolic Syndrome on Incident Vascular Events and Mortality in Four Rheumatic Diseases: An 8-Year Longitudinal Analysis
Chi Chiu Mok¹, Chiu Sum Chu¹, Ling Yin Ho², Kar Li Chan¹, Sau Mei Tse¹ and Chi Hung To³, ¹Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong, ²Dept of Medicine, Tuen Mun Hospital, Hong Kong SAR, Hong Kong, ³Medicine, Pok Oi Hospital, Hong Kong, Hong Kong
Background/Purpose: To study the effect of the metabolic syndrome (MetS) on incident vascular events and mortality in 4 rheumatic diseases over an 8-years’ follow-up. Methods:…
Abstract Number: 2161 • 2018 ACR/ARHP Annual Meeting
Hemophagocytic Syndrome in Adults and Association with Rheumatologic Diagnoses: US National Inpatient Trend over Nine Years
Prakash Paudel¹, Rashmi Dhital² and Dilli Poudel³, ¹Internal Medicine, Berkshire Medical Center, Pittsfield, MA, ²Reading Hospital-Tower Health System, West Reading, PA, ³Internal Medicine, Reading Hospital-Tower Health System, WEST READING, PA
Background/Purpose: Hemophagocytic syndrome (HPS) is a rare fatal condition of excessive immune activation. Association of hemophagocytosis with certain rheumatologic diseases is called macrophage activation syndrome…
Abstract Number: 2162 • 2018 ACR/ARHP Annual Meeting
The Prevalence, Incidence, and Determinants of Depression and Anxiety in Less Common Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis
Alyssa Howren^1,2,3, Enav Z. Zusman^1,2,3, J. Antonio Avina-Zubieta^2,4 and Mary A. De Vera^1,2,3, ¹Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, ²Arthritis Research Canada, Richmond, BC, Canada, ³Collaboration for Outcomes Research and Evaluation (CORE), Vancouver, BC, Canada, ⁴Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Individuals with systemic autoimmune rheumatic diseases (SARDs), including systemic lupus erythematosus (SLE), systemic sclerosis/scleroderma (SSc), Sjogren’s syndrome (SjS), dermatomyositis/polymyositis (DM/PM), and systemic vasculitides (SV),…
Abstract Number: 2163 • 2018 ACR/ARHP Annual Meeting
Prevalence and Incidence of Idiopathic Inflammatory Myopathies in Korea:a Nationwide Population-Based Study over 10 Years
Yoon-Kyoung Sung¹, Hyoungyoung Kim², Jisun Myung³, Eunwoo Nam³, Sun-Young Jung⁴, Eun Jin Jang⁵, Dae-Hyun Yoo⁶ and Soo-Kyung Cho², ¹Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South), ²Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South), ³Biostatistical Consulting and Research Lab, Medical Research Collaborating Center, Hanyang University, Seoul, Korea, Republic of (South), ⁴College of Pharmacy, Chung-Ang University, Seoul, Korea, Republic of (South), ⁵Information Statistics, Andong National University, Andong-si, Korea, Republic of (South), ⁶Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South)
Prevalence and Incidence of idiopathic Inflammatory Myopathies in Korea: a Nationwide Population-based Study over 10 yearsYoon-Kyoung Sung1, Hyoungyoung Kim1, Jisun Myung2, Eunwoo Nam2, Sun-young Jung3,…
Abstract Number: 2164 • 2018 ACR/ARHP Annual Meeting
IMPACT of a Systematic Screening of Multimorbidities in Patients with Chronic Inflammatory Rheumatic Diseases
Mégane Beurai-Weber Jr.¹, Audrey Jaussent², Guilhem du Cailar³, Marie-Christine Picot², François Roubille Sr.⁴, Jean-David Cohen⁵, Jacques Morel⁶, Jean Bousquet⁷, Pierre Fesler⁸, Bernard Combe⁹ and Claire Daien¹⁰, ¹Rheumatology Department, Lapeyronie Hospital and Montpellier University, MONTPELLIER, France, ²Department of medical information, Lapeyronie Hospital and Montpellier University, MONTPELLIER, France, ³Internal Medicine and Hypertension, Hopital Lapeyronie, Montpellier, France, ⁴Department of cardiology, Arnaud de Villeneuve Hospital and Montpellier University, MONTPELLIER, France, ⁵IMMUNO-RHEUMATOLOGY, CHU LAPEYRONIE, MONTPELLIER, France, ⁶Department of Rheumatology, University Hospital Lapeyronie, Montpellier, Montpellier, France, ⁷MACVIA-France, Lapeyronie Hospital and Montpellier University, MONTPELLIER, France, ⁸Internal medicine and hypertension, Lapeyronie Hospital and Montpellier University, Montpellier, France, ⁹University Hospital Lapeyronie, Department of Rheumatology, Montpellier, France, ¹⁰Rheumatology, University Hospital Lapeyronie, Montpellier, Montpellier, France
Background/Purpose: EULAR proposes to screen multimorbidities in chronic inflammatory rheumatic diseases. The aim of the study was to assess i) multimorbidities in patients with chronic…
Abstract Number: 2165 • 2018 ACR/ARHP Annual Meeting
The Trend of Utilization of Therapeutic Plasmapheresis Among Select Rheumatologic Diseases
Rashmi Dhital¹, Theresa Lynn², Priyadarshani Sharma², Sijan Basnet³, Prakash Paudel⁴, Swikrit Pyakurel⁵ and Dilli Poudel⁶, ¹Reading Hospital-Tower Health System, West Reading, PA, ²Reading Hospital, West Reading, PA, ³Internal Medicine, Reading Hospital, West Reading, PA, ⁴Internal Medicine, Berkshire Medical Center, Pittsfield, MA, ⁵Universal College of Medical Sciences, Bhairahawa, Nepal, ⁶Internal Medicine, Reading Hospital-Tower Health System, WEST READING, PA
Background/Purpose: Therapeutic plasma exchange (TPE) or plasmapheresis is a process in which plasma containing components, including autoantibodies and immune complexes, can be removed from the…
Abstract Number: 2166 • 2018 ACR/ARHP Annual Meeting
Treatment of Venous Thrombotic Events in Behçet Disease: A Systematic Literature Review
Iustina Janta¹, Roberto González², Tania Gudu³ and Indalecio Monteagudo¹, ¹Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, ²Rheumatology, Hospital general Universitario Gregorio Marañón, Madrid, Spain, ³University of Medicine Carol Davila Bucuresti, Romania, Bucuresti, Romania
Background/Purpose: Venous thrombosis (VT) is a serious and potentially life-threatening manifestation of Behçet disease (BD). However, there is little evidence of the management of the…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].